IL147669A0 - Method for transdifferentiation of body tissues - Google Patents

Method for transdifferentiation of body tissues

Info

Publication number
IL147669A0
IL147669A0 IL14766900A IL14766900A IL147669A0 IL 147669 A0 IL147669 A0 IL 147669A0 IL 14766900 A IL14766900 A IL 14766900A IL 14766900 A IL14766900 A IL 14766900A IL 147669 A0 IL147669 A0 IL 147669A0
Authority
IL
Israel
Prior art keywords
transdifferentiation
body tissues
tissues
Prior art date
Application number
IL14766900A
Other languages
English (en)
Original Assignee
Baranowitz Steven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baranowitz Steven filed Critical Baranowitz Steven
Publication of IL147669A0 publication Critical patent/IL147669A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/30—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cancer cells, e.g. reversion of tumour cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14766900A 1999-07-29 2000-07-31 Method for transdifferentiation of body tissues IL147669A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14627299P 1999-07-29 1999-07-29
US16855599P 1999-12-02 1999-12-02
PCT/US2000/021015 WO2001008691A1 (en) 1999-07-29 2000-07-31 Methods for transdifferentiation of body tissues

Publications (1)

Publication Number Publication Date
IL147669A0 true IL147669A0 (en) 2002-08-14

Family

ID=26843741

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14766900A IL147669A0 (en) 1999-07-29 2000-07-31 Method for transdifferentiation of body tissues
IL147669A IL147669A (en) 1999-07-29 2002-01-16 Method for transdifferentiation of body tissues

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147669A IL147669A (en) 1999-07-29 2002-01-16 Method for transdifferentiation of body tissues

Country Status (7)

Country Link
US (2) US6670397B1 (xx)
EP (1) EP1200101A4 (xx)
JP (2) JP2003528577A (xx)
AU (1) AU782396B2 (xx)
CA (1) CA2378140A1 (xx)
IL (2) IL147669A0 (xx)
WO (1) WO2001008691A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087993A1 (en) * 1999-07-29 2007-04-19 Steven Baranowitz Method for transdifferentiation of body tissues
JP2003528577A (ja) * 1999-07-29 2003-09-30 バラノヴィッツ，スティーブン 身体組織の分化転換方法
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
DK1226233T3 (da) 1999-08-05 2011-10-03 Abt Holding Co Multipotente voksne stamceller og fremgangsmåder til isolering heraf
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
US6864243B1 (en) 2000-05-12 2005-03-08 Inspire Pharmaceuticals, Inc. Method for treating retinal degeneration with purinergic receptor agonists
JP2004529621A (ja) 2001-02-14 2004-09-30 ティー ファークト，レオ 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
CA2473503C (en) 2002-01-14 2010-01-05 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
AU2003298016A1 (en) 2002-11-27 2004-06-23 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
JP2006517807A (ja) * 2002-12-30 2006-08-03 パーデュー・リサーチ・ファウンデーション 中枢神経系の損傷の治療方法
CA2542124A1 (en) * 2003-10-10 2005-04-28 Cellular Bioengineering, Inc. Composition and methods for cell culturing and tissue culture platforms
NZ567082A (en) 2005-10-14 2012-08-31 Univ Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
WO2008063675A2 (en) 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
US7897363B2 (en) 2007-06-12 2011-03-01 Phylonix Pharmaceuticals, Inc. Methods of screening an agent for an activity in an isolated eye of a teleost
AU2009205886B2 (en) 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
US9057051B2 (en) 2008-10-31 2015-06-16 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte progenitor phenotypes, cells produced by the methods, and methods of using the cells
TWI450228B (zh) * 2010-01-15 2014-08-21 私立中原大學 A method of simulating spinal surgery on a computer system
EP2568991B3 (en) 2010-05-12 2018-11-28 ABT Holding Company Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
EP2609191B1 (en) 2010-08-24 2017-11-22 Regents Of The University Of Minnesota Non-static suspension culture of cell aggregates
CN105338989B (zh) 2013-04-12 2022-04-08 赛维里奥·拉弗朗切西卡 改进用于移植的器官
AU2016243612A1 (en) 2015-03-31 2017-10-12 The University Of North Carolina At Chapel Hill Delivery vehicles for stem cells and uses thereof
NL2019618B1 (en) 2017-09-22 2019-03-28 Ncardia B V In vitro method for providing stem cell derived cardiomyocytes
WO2019073055A1 (en) 2017-10-13 2019-04-18 Imba - Institut Für Molekulare Biotechnologie Gmbh ENHANCED REPROGRAMMING OF SOMATIC CELLS
US20230134859A1 (en) * 2020-03-31 2023-05-04 Sky Pharma Co., Ltd. Method for screening for, method for producing, and method for designing drug active ingredients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001097A1 (en) * 1993-06-30 1995-01-12 Board Of Regents, The University Of Texas System Nucleotide preparation and uses thereof in wound healing
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
JP2003528577A (ja) * 1999-07-29 2003-09-30 バラノヴィッツ，スティーブン 身体組織の分化転換方法

Also Published As

Publication number Publication date
JP2011139705A (ja) 2011-07-21
US6670397B1 (en) 2003-12-30
CA2378140A1 (en) 2001-02-08
JP2003528577A (ja) 2003-09-30
AU6754500A (en) 2001-02-19
EP1200101A1 (en) 2002-05-02
US20030229008A1 (en) 2003-12-11
WO2001008691A1 (en) 2001-02-08
IL147669A (en) 2009-05-04
AU782396B2 (en) 2005-07-21
US7176189B2 (en) 2007-02-13
EP1200101A4 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
IL147669A0 (en) Method for transdifferentiation of body tissues
GB9808764D0 (en) Magnetic stimulators for neuro-muscular tissue
GB2354949B (en) Apparatus for treating body tissues with electricty
HUP0102536A3 (en) Device and method for resecting body tissues
HK1027986A1 (en) Method of sterilization
AU5276600A (en) Kit for flushing medical devices and method of preparing the flushing solution
HUP0201393A3 (en) Use of xenon for treating neurointoxications
HUP0203123A3 (en) Process for preparation of polyglutamate-therapeutic agent conjugates
HU0001471D0 (en) New method of treatment
PL348107A1 (en) Therapy for improving cognition
EG23819A (en) Method for preparing of l-phenylephrine-hydrochloride
IL146769A0 (en) Method of sterilizing
HUP0200738A3 (en) Method of the treatment of incontinence
AP2000001966A0 (en) Method for reduction of nickel
AU1878201A (en) Composition for the treatment of damaged tissue
HUP0203364A3 (en) Method for preparation of 3-substituted-4-arylquinolin-2-one derivatives
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
IL138691A (en) Process for the preparation of 3-acyl-indoles
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
HUP0001558A3 (en) Process for the preparation of pirlindole hydrochloride
PL341752A1 (en) Method of obtaining aryloamino hydroxyantraquinones
GB9922482D0 (en) Method of diagnosis
HU9904575D0 (en) Process for preparation of n-alkoxy-methyl-acidamides
IL146505A0 (en) Methods for the preparation of tetrahydroisoquinolinephenol derivatives
SI1068184T1 (en) N-aryloxyethylamine derivatives for the treatment of depression